These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 9016218

  • 1. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Sundaresan SR, Patterson GA, Cooper JD.
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [Abstract] [Full Text] [Related]

  • 2. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 3. Role of positron emission tomography in staging esophageal cancer.
    Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP.
    Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
    [Abstract] [Full Text] [Related]

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 5. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
    Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, Siegel BA, Cooper JD.
    Ann Thorac Surg; 1997 Sep; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Imaging features of primary and recurrent esophageal cancer at FDG PET.
    Skehan SJ, Brown AL, Thompson M, Young JE, Coates G, Nahmias C.
    Radiographics; 2000 Sep; 20(3):713-23. PubMed ID: 10835124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 11. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V, Harmon M, Johnston C, Fagan AJ, Claxton Z, Ravi N, O'Toole D, Muldoon C, Keogan M, Reynolds JV, Meaney JF.
    Dig Surg; 2015 Oct 15; 32(5):397-408. PubMed ID: 26315570
    [Abstract] [Full Text] [Related]

  • 12. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
    Pifarré-Montaner P, Fernández-León A, de Juan R, del Ama-Salvador ME, Galán M, Gámez-Cenzano C, Sans M.
    Rev Esp Med Nucl; 2009 Oct 15; 28(3):101-5. PubMed ID: 19558949
    [Abstract] [Full Text] [Related]

  • 13. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 15; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 14. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2006 Aug 15; (243):116-22. PubMed ID: 16782630
    [Abstract] [Full Text] [Related]

  • 15. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 16. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM, Balan A, Naik K, Mirsadraee S, Scarsbrook AF.
    Clin Radiol; 2008 Jul 20; 63(7):765-73. PubMed ID: 18555034
    [Abstract] [Full Text] [Related]

  • 17. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS.
    Radiology; 2003 Jun 20; 227(3):764-70. PubMed ID: 12773680
    [Abstract] [Full Text] [Related]

  • 18. Is FDG-PET indicated for superficial esophageal cancer?
    Little SG, Rice TW, Bybel B, Mason DP, Murthy SC, Falk GW, Rybicki LA, Blackstone EH.
    Eur J Cardiothorac Surg; 2007 May 20; 31(5):791-6. PubMed ID: 17337344
    [Abstract] [Full Text] [Related]

  • 19. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
    Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, Kim BT.
    J Nucl Med; 2000 May 20; 41(5):808-15. PubMed ID: 10809196
    [Abstract] [Full Text] [Related]

  • 20. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.